IDH2 and astrocytoma (excluding glioblastoma): EGFR alterations have been linked to glioblastoma, and tumors previously defined as diffuse grade 2–3 astrocytoma, IDH wildtype are currently considered glioblastomas if they harbor EGFR amplification (5).